Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WHI Follow-Up Survey Includes Tracking Of Osteoporosis Drug Uptake

Executive Summary

NIH plans to track the uptake of osteoporosis prevention therapies among women formerly enrolled in the discontinued Prempro arm of the Women's Health Initiative study
Advertisement

Related Content

Hormone Therapy Class Labeling Uses Wyeth Template; Appeals Due By March
Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review
Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review
Advertisement
UsernamePublicRestriction

Register

PS041141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel